Table of Contents Author Guidelines Submit a Manuscript
Advances in Pharmacological Sciences
Volume 2015, Article ID 384750, 11 pages
http://dx.doi.org/10.1155/2015/384750
Review Article

Melatonin and Ischemic Stroke: Mechanistic Roles and Action

1Department of Medical Elementology and Toxicology, Jamia Hamdard (Hamdard University), New Delhi 110062, India
2Department of Biochemistry, Jamia Hamdard (Hamdard University), New Delhi 110062, India

Received 31 May 2015; Revised 9 August 2015; Accepted 19 August 2015

Academic Editor: Ivar von Kugelgen

Copyright © 2015 Syed Suhail Andrabi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. D. Mathers, T. Boerma, and D. Ma Fat, “Global and regional causes of death,” British Medical Bulletin, vol. 92, no. 1, pp. 7–32, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. R. W. V. Flynn, R. S. M. MacWalter, and A. S. F. Doney, “The cost of cerebral ischaemia,” Neuropharmacology, vol. 55, no. 3, pp. 250–256, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. R. S. Pandya, L. Mao, H. Zhou et al., “Central nervous system agents for ischemic stroke: neuroprotection mechanisms,” Central Nervous System Agents in Medicinal Chemistry, vol. 11, no. 2, pp. 81–97, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. Y. Jin, N. Raviv, A. Barnett et al., “The shh signaling pathway is upregulated in multiple cell types in cortical ischemia and influences the outcome of stroke in an animal model,” PLoS ONE, vol. 10, no. 4, Article ID e0124657, 2015. View at Publisher · View at Google Scholar
  5. B. Wali, T. Ishrat, S. Won, D. G. Stein, and I. Sayeed, “Progesterone in experimental permanent stroke: a dose-response and therapeutic time-window study,” Brain, vol. 137, no. 2, pp. 486–502, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. A. Canazza, L. Minati, C. Boffano, E. Parati, and S. Binks, “Experimental models of brain ischemia: a review of techniques, magnetic resonance imaging, and investigational cell-based therapies,” Frontiers in Neurology, vol. 5, article 19, 2014. View at Publisher · View at Google Scholar · View at Scopus
  7. R. Jin, X. Zhu, and G. Li, “Embolic middle cerebral artery occlusion (MCAO) for ischemic stroke with homologous blood clots in rats,” Journal of Visualized Experiments, no. 91, Article ID 51956, 2014. View at Publisher · View at Google Scholar
  8. K.-A. Hossmann, “The two pathophysiologies of focal brain ischemia: implications for translational stroke research,” Journal of Cerebral Blood Flow and Metabolism, vol. 32, no. 7, pp. 1310–1316, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. W.-D. Heiss, “The ischemic penumbra: how does tissue injury evolve?” Annals of the New York Academy of Sciences, vol. 1268, no. 1, pp. 26–34, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. T. M. Woodruff, J. Thundyil, S.-C. Tang, C. G. Sobey, S. M. Taylor, and T. V. Arumugam, “Pathophysiology, treatment, and animal and cellular models of human ischemic stroke,” Molecular Neurodegeneration, vol. 6, no. 1, article 11, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. A. Purushotham, B. C. V. Campbell, M. Straka et al., “Apparent diffusion coefficient threshold for delineation of ischemic core,” International Journal of Stroke, vol. 10, no. 3, pp. 348–353, 2015. View at Publisher · View at Google Scholar · View at Scopus
  12. M. Fisher and B. Bastan, “Identifying and utilizing the ischemic penumbra,” Neurology, vol. 79, no. 13, pp. S79–S85, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. M. Fisher and B. Bastan, “Identifying and utilizing the ischemic penumbra,” Neurology, vol. 79, no. 13, supplement 1, pp. S79–S85, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. H. Li, N. Zhang, H.-Y. Lin et al., “Histological, cellular and behavioral assessments of stroke outcomes after photothrombosis-induced ischemia in adult mice,” BMC Neuroscience, vol. 15, article 58, 2014. View at Publisher · View at Google Scholar · View at Scopus
  15. T. Chiang, R. O. Messing, and W. H. Chou, “Mouse model of middle cerebral artery occlusion,” Journal of Visualized Experiments, vol. 13, no. 48, p. 2761, 2011. View at Google Scholar
  16. M. Pompili, P. Venturini, D. A. Lamis et al., “Suicide in stroke survivors: epidemiology and prevention,” Drugs and Aging, vol. 32, no. 1, pp. 21–29, 2014. View at Publisher · View at Google Scholar · View at Scopus
  17. H. Sies, “Oxidative stress: a concept in redox biology and medicine,” Redox Biology, vol. 4, pp. 180–183, 2015. View at Publisher · View at Google Scholar · View at Scopus
  18. B. Halliwell, “Free radicals and antioxidants—quo vadis?” Trends in Pharmacological Sciences, vol. 32, no. 3, pp. 125–130, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. M. L. Dallas, J. P. Boyle, C. J. Milligan et al., “Carbon monoxide protects against oxidant-induced apoptosis via inhibition of Kv2.1,” The FASEB Journal, vol. 25, no. 5, pp. 1519–1530, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. J. W. Thompson, S. V. Narayanan, and M. A. Perez-Pinzon, “Redox signaling pathways involved in neuronal ischemic preconditioning,” Current Neuropharmacology, vol. 10, no. 4, pp. 354–369, 2012. View at Publisher · View at Google Scholar · View at Scopus
  21. R. M. Adibhatla and J. F. Hatcher, “Phospholipase A(2), reactive oxygen species, and lipid peroxidation in CNS pathologies,” Journal of Biochemistry and Molecular Biology, vol. 41, no. 8, pp. 560–567, 2008. View at Google Scholar · View at Scopus
  22. H.-M. Gao, H. Zhou, and J.-S. Hong, “NADPH oxidases: novel therapeutic targets for neurodegenerative diseases,” Trends in Pharmacological Sciences, vol. 33, no. 6, pp. 295–303, 2012. View at Publisher · View at Google Scholar · View at Scopus
  23. J. C. Lee and M. H. Won, “Neuroprotection of antioxidant enzymes against transient global cerebral ischemia in gerbils,” Anatomy & Cell Biology, vol. 47, no. 3, pp. 149–156, 2014. View at Publisher · View at Google Scholar
  24. K. Niizuma, H. Yoshioka, H. Chen et al., “Mitochondrial and apoptotic neuronal death signaling pathways in cerebral ischemia,” Biochimica et Biophysica Acta—Molecular Basis of Disease, vol. 1802, no. 1, pp. 92–99, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. T. H. Sanderson, C. A. Reynolds, R. Kumar, K. Przyklenk, and M. Hüttemann, “Molecular mechanisms of ischemia-reperfusion injury in brain: pivotal role of the mitochondrial membrane potential in reactive oxygen species generation,” Molecular Neurobiology, vol. 47, no. 1, pp. 9–23, 2013. View at Publisher · View at Google Scholar · View at Scopus
  26. T. W. Lai, S. Zhang, and Y. T. Wang, “Excitotoxicity and stroke: identifying novel targets for neuroprotection,” Progress in Neurobiology, vol. 115, pp. 157–188, 2014. View at Publisher · View at Google Scholar · View at Scopus
  27. A. Lau and M. Tymianski, “Glutamate receptors, neurotoxicity and neurodegeneration,” Pflügers Archiv, vol. 460, no. 2, pp. 525–542, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. A. M. Dolga, N. Terpolilli, F. Kepura et al., “KCa2 channels activation prevents [Ca2+]i deregulation and reduces neuronal death following glutamate toxicity and cerebral ischemia,” Cell Death and Disease, vol. 2, no. 4, article e147, 2011. View at Publisher · View at Google Scholar · View at Scopus
  29. S. A. Andrabi, H. C. Kang, J.-F. Haince et al., “Iduna protects the brain from glutamate excitotoxicity and stroke by interfering with poly(ADP-ribose) polymer-induced cell death,” Nature Medicine, vol. 17, no. 6, pp. 692–699, 2011. View at Publisher · View at Google Scholar · View at Scopus
  30. Q. Zhao, S. Wang, Y. Li et al., “The role of the mitochondrial calcium uniporter in cerebral ischemia/reperfusion injury in rats involves regulation of mitochondrial energy metabolism,” Molecular Medicine Reports, vol. 7, no. 4, pp. 1073–1080, 2013. View at Publisher · View at Google Scholar · View at Scopus
  31. L. C. Constantino, C. I. Tasca, and C. R. Boeck, “The role of NMDA receptors in the development of brain resistance through pre- and postconditioning,” Aging and Disease, vol. 5, no. 6, pp. 430–441, 2014. View at Google Scholar
  32. M. M. Harraz, S. M. Eacker, X. Wang, T. M. Dawson, and V. L. Dawson, “MicroRNA-223 is neuroprotective by targeting glutamate receptors,” Proceedings of the National Academy of Sciences of the United States of America, vol. 109, no. 46, pp. 18962–18967, 2012. View at Publisher · View at Google Scholar · View at Scopus
  33. X. Wang, B. E. Figueroa, I. G. Stavrovskaya et al., “Methazolamide and melatonin inhibit mitochondrial cytochrome C release and are neuroprotective in experimental models of ischemic injury,” Stroke, vol. 40, no. 5, pp. 1877–1885, 2009. View at Publisher · View at Google Scholar · View at Scopus
  34. P. Bhattacharya, A. K. Pandey, S. Paul, and R. Patnaik, “Melatonin renders neuroprotection by protein kinase C mediated aquaporin-4 inhibition in animal model of focal cerebral ischemia,” Life Sciences, vol. 100, no. 2, pp. 97–109, 2014. View at Publisher · View at Google Scholar · View at Scopus
  35. S.-H. Tai, H.-Y. Chen, E.-J. Lee et al., “Melatonin inhibits postischemic matrix metalloproteinase-9 (MMP-9) activation via dual modulation of plasminogen/plasmin system and endogenous MMP inhibitor in mice subjected to transient focal cerebral ischemia,” Journal of Pineal Research, vol. 49, no. 4, pp. 332–341, 2010. View at Publisher · View at Google Scholar · View at Scopus
  36. X. Hu, P. Li, Y. Guo et al., “Microglia/macrophage polarization dynamics reveal novel mechanism of injury expansion after focal cerebral ischemia,” Stroke, vol. 43, no. 11, pp. 3063–3070, 2012. View at Publisher · View at Google Scholar · View at Scopus
  37. W.-S. Juan, S.-Y. Huang, C.-C. Chang et al., “Melatonin improves neuroplasticity by upregulating the growth-associated protein-43 (GAP-43) and NMDAR postsynaptic density-95 (PSD-95) proteins in cultured neurons exposed to glutamate excitotoxicity and in rats subjected to transient focal cerebral ischemia even during a long-term recovery period,” Journal of Pineal Research, vol. 56, no. 2, pp. 213–223, 2014. View at Publisher · View at Google Scholar · View at Scopus
  38. H. Li, Y. Wang, D. Feng et al., “Alterations in the time course of expression of the Nox family in the brain in a rat experimental cerebral ischemia and reperfusion model: effects of melatonin,” Journal of Pineal Research, vol. 57, no. 1, pp. 110–119, 2014. View at Publisher · View at Google Scholar · View at Scopus
  39. Y.-X. Han, S.-H. Zhang, X.-M. Wang, and J.-B. Wu, “Inhibition of mitochondria responsible for the anti-apoptotic effects of melatonin during ischemia-reperfusion,” Journal of Zhejiang University Science B, vol. 7, no. 2, pp. 142–147, 2006. View at Publisher · View at Google Scholar · View at Scopus
  40. E. Kilic, Ü. Kilic, M. Bacigaluppi et al., “Delayed melatonin administration promotes neuronal survival, neurogenesis and motor recovery, and attenuates hyperactivity and anxiety after mild focal cerebral ischemia in mice,” Journal of Pineal Research, vol. 45, no. 2, pp. 142–148, 2008. View at Publisher · View at Google Scholar · View at Scopus
  41. J. Song, S. M. Kang, W. T. Lee, K. A. Park, K. M. Lee, and J. E. Lee, “The beneficial effect of melatonin in brain endothelial cells against oxygen-glucose deprivation followed by reperfusion-induced injury,” Oxidative Medicine and Cellular Longevity, vol. 2014, Article ID 639531, 14 pages, 2014. View at Publisher · View at Google Scholar
  42. S. A. Andrabi, I. Sayeed, D. Siemen, G. Wolf, and T. F. W. Horn, “Direct inhibition of the mitochondrial permeability transition pore: a possible mechanism responsible for anti-apoptotic effects of melatonin,” The FASEB Journal, vol. 18, no. 7, pp. 869–871, 2004. View at Google Scholar · View at Scopus
  43. C. Thornton and H. Hagberg, “Role of mitochondria in apoptotic and necroptotic cell death in the developing brain,” Clinica Chimica Acta, 2015. View at Publisher · View at Google Scholar · View at Scopus
  44. M. H. Singh, S. M. Brooke, I. Zemlyak, and R. M. Sapolsky, “Evidence for caspase effects on release of cytochrome c and AIF in a model of ischemia in cortical neurons,” Neuroscience Letters, vol. 469, no. 2, pp. 179–183, 2010. View at Publisher · View at Google Scholar · View at Scopus
  45. L. Portt, G. Norman, C. Clapp, M. Greenwood, and M. T. Greenwood, “Anti-apoptosis and cell survival: a review,” Biochimica et Biophysica Acta—Molecular Cell Research, vol. 1813, no. 1, pp. 238–259, 2011. View at Publisher · View at Google Scholar · View at Scopus
  46. S. Fulda, A. M. Gorman, O. Hori, and A. Samali, “Cellular stress responses: cell survival and cell death,” International Journal of Cell Biology, vol. 2010, Article ID 214074, 23 pages, 2010. View at Publisher · View at Google Scholar · View at Scopus
  47. E. A. Jonas, G. A. Porter Jr., G. Beutner, N. Mnatsakanyan, and K. N. Alavian, “Cell death disguised: the mitochondrial permeability transition pore as the c-subunit of the F1FO ATP synthase,” Pharmacological Research, 2015. View at Publisher · View at Google Scholar
  48. V. Giorgio, S. S. von Stockum, M. Antoniel et al., “Dimers of mitochondrial ATP synthase form the permeability transition pore,” Proceedings of the National Academy of Sciences of the United States of America, vol. 110, no. 15, pp. 5887–5892, 2013. View at Publisher · View at Google Scholar · View at Scopus
  49. H. Huang, X. Hu, C. O. Eno, G. Zhao, C. Li, and C. White, “An interaction between Bcl-xL and the voltage-dependent anion channel (VDAC) promotes mitochondrial Ca2+ uptake,” Journal of Biological Chemistry, vol. 288, no. 27, pp. 19870–19881, 2013. View at Publisher · View at Google Scholar · View at Scopus
  50. J. Karch, J. Q. Kwong, and A. R. Burr, “Bax and Bak function as the outer membrane component of the mitochondrial permeability pore in regulating necrotic cell death in mice,” Elife, vol. 27, no. 2, Article ID e00772, 2013. View at Google Scholar
  51. S.-Y. Ryu, P. M. Peixoto, O. Teijido, L. M. Dejean, and K. W. Kinnally, “Role of mitochondrial ion channels in cell death,” BioFactors, vol. 36, no. 4, pp. 255–263, 2010. View at Publisher · View at Google Scholar · View at Scopus
  52. Q. Chen, H. Xu, A. Xu et al., “Inhibition of Bcl-2 sensitizes mitochondrial permeability transition pore (MPTP) opening in ischemia-damaged mitochondria,” PLOS ONE, vol. 10, no. 3, Article ID e0118834, 2015. View at Publisher · View at Google Scholar
  53. L. M. Dejean, S.-Y. Ryu, S. Martinez-Caballero, O. Teijido, P. M. Peixoto, and K. W. Kinnally, “MAC and Bcl-2 family proteins conspire in a deadly plot,” Biochimica et Biophysica Acta—Bioenergetics, vol. 1797, no. 6-7, pp. 1231–1238, 2010. View at Publisher · View at Google Scholar · View at Scopus
  54. C. Brenner and M. Moulin, “Physiological roles of the permeability transition pore,” Circulation Research, vol. 111, no. 9, pp. 1237–1247, 2012. View at Publisher · View at Google Scholar · View at Scopus
  55. R. Abeti and A. Y. Abramo, “Mitochondrial Ca2+ in neurodegenerative disorders,” Pharmacological Research, vol. 6618, no. 15, pp. 91–92, 2015. View at Google Scholar
  56. J. Yuan, “Neuroprotective strategies targeting apoptotic and necrotic cell death for stroke,” Apoptosis, vol. 14, no. 4, pp. 469–477, 2009. View at Publisher · View at Google Scholar · View at Scopus
  57. M. A. Moskowitz, E. H. Lo, and C. Iadecola, “The science of stroke: mechanisms in search of treatments,” Neuron, vol. 67, no. 2, pp. 181–198, 2010. View at Publisher · View at Google Scholar · View at Scopus
  58. N. R. Sims and H. Muyderman, “Mitochondria, oxidative metabolism and cell death in stroke,” Biochimica et Biophysica Acta, vol. 1802, no. 1, pp. 80–91, 2010. View at Publisher · View at Google Scholar · View at Scopus
  59. H. Zhang, Y.-W. Zhang, Y. Chen et al., “Appoptosin is a novel pro-apoptotic protein and mediates cell death in neurodegeneration,” Journal of Neuroscience, vol. 32, no. 44, pp. 15565–15576, 2012. View at Publisher · View at Google Scholar · View at Scopus
  60. B. R. S. Broughton, D. C. Reutens, and C. G. Sobey, “Apoptotic mechanisms after cerebral ischemia,” Stroke, vol. 40, no. 5, pp. e331–e339, 2009. View at Publisher · View at Google Scholar · View at Scopus
  61. L. Jie, C. Yuqin, D. Yao, H. Shuai, and W. Yuanyuan, “Occlusion of middle cerebral artery induces apoptosis of cerebellar cortex neural cells via caspase-3 in rats,” Turkish Neurosurgery, vol. 21, no. 4, pp. 567–574, 2011. View at Publisher · View at Google Scholar · View at Scopus
  62. S. Nowsheen and E. S. Yang, “The intersection between DNA damage response and cell death pathways,” Experimental Oncology, vol. 34, no. 3, pp. 243–254, 2012. View at Google Scholar · View at Scopus
  63. E. Norberg, S. Orrenius, and B. Zhivotovsky, “Mitochondrial regulation of cell death: processing of apoptosis-inducing factor (AIF),” Biochemical and Biophysical Research Communications, vol. 396, no. 1, pp. 95–100, 2010. View at Publisher · View at Google Scholar · View at Scopus
  64. E.-M. Öxler, A. Dolga, and C. Culmsee, “AIF depletion provides neuroprotection through a preconditioning effect,” Apoptosis, vol. 17, no. 10, pp. 1027–1038, 2012. View at Publisher · View at Google Scholar · View at Scopus
  65. B. M. Polster, “AIF, reactive oxygen species, and neurodegeneration: a ‘complex’ problem,” Neurochemistry International, vol. 62, no. 5, pp. 695–702, 2013. View at Publisher · View at Google Scholar · View at Scopus
  66. N. Doti, C. Reuther, P. L. Scognamiglio et al., “Inhibition of the AIF/CypA complex protects against intrinsic death pathways induced by oxidative stress,” Cell Death & Disease, vol. 16, no. 5, article e993, 2014. View at Google Scholar
  67. S. A. Andrabi, T. M. Dawson, and V. L. Dawson, “Mitochondrial and nuclear cross talk in cell death: parthanatos,” Annals of the New York Academy of Sciences, vol. 1147, pp. 233–241, 2008. View at Publisher · View at Google Scholar · View at Scopus
  68. E. Batnasan, R. Wang, J. Wen et al., “17-Beta estradiol inhibits oxidative stress-induced accumulation of AIF into nucleolus and PARP1-dependent cell death via estrogen receptor alpha,” Toxicology Letters, vol. 232, no. 1, pp. 1–9, 2015. View at Publisher · View at Google Scholar · View at Scopus
  69. K. K. David, S. A. Andrabi, T. M. Dawson, and V. L. Dawson, “Parthanatos, a messenger of death,” Frontiers in Bioscience, vol. 14, no. 3, pp. 1116–1128, 2009. View at Publisher · View at Google Scholar · View at Scopus
  70. Y. Wang, N. S. Kim, X. Li et al., “Calpain activation is not required for AIF translocation in PARP-1-dependent cell death (parthanatos),” Journal of Neurochemistry, vol. 110, no. 2, pp. 687–696, 2009. View at Publisher · View at Google Scholar · View at Scopus
  71. S.-H. Baek, O.-N. Bae, E.-K. Kim, and S.-W. Yu, “Induction of mitochondrial dysfunction by poly(ADP-ribose) polymer: implication for neuronal cell death,” Molecules and Cells, vol. 36, no. 3, pp. 258–266, 2013. View at Publisher · View at Google Scholar · View at Scopus
  72. J. Pei, X. You, and Q. Fu, “Inflammation in the pathogenesis of ischemic stroke,” Frontiers in Bioscience, vol. 20, no. 4, pp. 772–783, 2015. View at Publisher · View at Google Scholar · View at Scopus
  73. C. Iadecola and J. Anrather, “The immunology of stroke: from mechanisms to translation,” Nature Medicine, vol. 17, no. 7, pp. 796–808, 2011. View at Publisher · View at Google Scholar · View at Scopus
  74. M. Kawabori and M. A. Yenari, “Inflammatory responses in brain ischemia,” Current Medicinal Chemistry, vol. 22, no. 10, pp. 1258–1277, 2015. View at Publisher · View at Google Scholar
  75. G. Yilmaz and D. N. Granger, “Leukocyte recruitment and ischemic brain injury,” NeuroMolecular Medicine, vol. 12, no. 2, pp. 193–204, 2010. View at Publisher · View at Google Scholar · View at Scopus
  76. Á. Chamorro, A. Meisel, A. M. Planas, X. Urra, D. Van de Beek, and R. Veltkamp, “The immunology of acute stroke,” Nature Reviews Neurology, vol. 8, no. 7, pp. 401–410, 2012. View at Publisher · View at Google Scholar · View at Scopus
  77. B. M. Famakin, “The immune response to acute focal cerebral ischemia and associated post-stroke immunodepression: a focused review,” Aging and Disease, vol. 5, no. 5, pp. 307–326, 2014. View at Publisher · View at Google Scholar · View at Scopus
  78. L. Wu, K. Zhang, G. Hu, H. Yang, C. Xie, and X. Wu, “Inflammatory response and neuronal necrosis in rats with cerebral ischemia,” Neural Regeneration Research, vol. 9, no. 19, pp. 1753–1762, 2014. View at Publisher · View at Google Scholar · View at Scopus
  79. T. Dziedzic, “Systemic inflammation as a therapeutic target in acute ischemic stroke,” Expert Review of Neurotherapeutics, vol. 15, no. 5, pp. 523–531, 2015. View at Publisher · View at Google Scholar
  80. D. N. Doll, T. L. Barr, and J. W. Simpkins, “Cytokines: their role in stroke and potential use as biomarkers and therapeutic targets,” Aging and Disease, vol. 5, no. 5, pp. 294–306, 2014. View at Publisher · View at Google Scholar · View at Scopus
  81. H. C. Pan, C. N. Yang, Y. W. Hung et al., “Reciprocal modulation of C/EBP-α and C/EBP-β by IL-13 in activated microglia prevents neuronal death,” European Journal of Immunology, vol. 43, no. 11, pp. 2854–2865, 2013. View at Publisher · View at Google Scholar · View at Scopus
  82. E. C. Koellhoffer and L. D. McCullough, “The effects of estrogen in ischemic stroke,” Translational Stroke Research, vol. 4, no. 4, pp. 390–401, 2013. View at Publisher · View at Google Scholar · View at Scopus
  83. D. A. Schreihofer and Y. Ma, “Estrogen receptors and ischemic neuroprotection: who, what, where, and when?” Brain Research, vol. 1514, pp. 107–122, 2013. View at Publisher · View at Google Scholar · View at Scopus
  84. I. Sayeed and D. G. Stein, “Progesterone as a neuroprotective factor in traumatic and ischemic brain injury,” Progress in Brain Research, vol. 175, pp. 219–237, 2009. View at Publisher · View at Google Scholar · View at Scopus
  85. H.-M. Zhang and Y. Zhang, “Melatonin: a well-documented antioxidant with conditional pro-oxidant actions,” Journal of Pineal Research, vol. 57, no. 2, pp. 131–146, 2014. View at Publisher · View at Google Scholar · View at Scopus
  86. A. Galano, D. X. Tan, and R. J. Reiter, “Melatonin as a natural ally against oxidative stress: a physicochemical examination,” Journal of Pineal Research, vol. 51, no. 1, pp. 1–16, 2011. View at Publisher · View at Google Scholar · View at Scopus
  87. J. J. García, L. López-Pingarrón, P. Almeida-Souza et al., “Protective effects of melatonin in reducing oxidative stress and in preserving the fluidity of biological membranes: a review,” Journal of Pineal Research, vol. 56, no. 3, pp. 225–237, 2014. View at Publisher · View at Google Scholar · View at Scopus
  88. E. Miller, A. Morel, L. Saso, and J. Saluk, “Melatonin redox activity. Its potential clinical applications in neurodegenerative disorders,” Current Topics in Medicinal Chemistry, vol. 15, no. 2, pp. 163–169, 2015. View at Publisher · View at Google Scholar
  89. A. Chattoraj, T. Liu, L. S. Zhang, Z. Huang, and J. Borjigin, “Melatonin formation in mammals: in vivo perspectives,” Reviews in Endocrine and Metabolic Disorders, vol. 10, no. 4, pp. 237–243, 2009. View at Publisher · View at Google Scholar · View at Scopus
  90. J. B. Zawilska, D. J. Skene, and J. Arendt, “Physiology and pharmacology of melatonin in relation to biological rhythms,” Pharmacological Reports, vol. 61, no. 3, pp. 383–410, 2009. View at Publisher · View at Google Scholar · View at Scopus
  91. P. M. Iuvone, G. Tosini, N. Pozdeyev, R. Haque, D. C. Klein, and S. S. Chaurasia, “Circadian clocks, clock networks, arylalkylamine N-acetyltransferase, and melatonin in the retina,” Progress in Retinal and Eye Research, vol. 24, no. 4, pp. 433–456, 2005. View at Publisher · View at Google Scholar · View at Scopus
  92. I. Semak, E. Korik, M. Antonova, J. Wortsman, and A. Slominski, “Metabolism of melatonin by cytochrome P450s in rat liver mitochondria and microsomes,” Journal of Pineal Research, vol. 45, no. 4, pp. 515–523, 2008. View at Publisher · View at Google Scholar · View at Scopus
  93. B. Claustrat and J. Leston, “Melatonin: physiological effects in humans,” Neurochirurgie, vol. 61, no. 2-3, pp. 77–84, 2015. View at Publisher · View at Google Scholar
  94. R. Hardeland and B. Poeggeler, “Melatonin and synthetic melatonergic agonists: actions and metabolism in the central nervous system,” Central Nervous System Agents in Medicinal Chemistry, vol. 12, no. 3, pp. 189–216, 2012. View at Publisher · View at Google Scholar · View at Scopus
  95. B. P. Lucke-Wold, K. E. Smith, L. Nguyen et al., “Sleep disruption and the sequelae associated with traumatic brain injury,” Neuroscience & Biobehavioral Reviews, vol. 55, pp. 68–77, 2015. View at Publisher · View at Google Scholar
  96. B. V. Jardim, L. C. Ferreira, T. F. Borin et al., “Evaluation of the anti-angiogenic action of melatonin in breast cancer,” BMC Proceedings, vol. 7, supplement 2, article P11, 2003. View at Publisher · View at Google Scholar
  97. A. Korkmaz, T. Topal, D.-X. Tan, and R. J. Reiter, “Role of melatonin in metabolic regulation,” Reviews in Endocrine and Metabolic Disorders, vol. 10, no. 4, pp. 261–270, 2009. View at Publisher · View at Google Scholar · View at Scopus
  98. B. Lacoste, D. Angeloni, S. Dominguez-Lopez et al., “Anatomical and cellular localization of melatonin MT1 and MT2 receptors in the adult rat brain,” Journal of Pineal Research, vol. 58, no. 4, pp. 397–417, 2015. View at Publisher · View at Google Scholar
  99. E. R. V. Rios, E. T. Venncio, N. F. M. Rocha et al., “Melatonin: pharmacological aspects and clinical trends,” International Journal of Neuroscience, vol. 120, no. 9, pp. 583–590, 2010. View at Publisher · View at Google Scholar · View at Scopus
  100. Y.-H. Wu, J. Ursinus, J.-N. Zhou et al., “Alterations of melatonin receptors MT1 and MT2 in the hypothalamic suprachiasmatic nucleus during depression,” Journal of Affective Disorders, vol. 148, no. 2-3, pp. 357–367, 2013. View at Publisher · View at Google Scholar · View at Scopus
  101. B. M. Escribano, A. Colín-González, A. Santamaría, and I. Túnez, “The role of melatonin in multiple sclerosis, Huntington's disease and cerebral ischemia,” CNS & Neurological Disorders—Drug Targets, vol. 13, no. 6, pp. 1096–1119, 2014. View at Publisher · View at Google Scholar
  102. G. Sarlak, A. Jenwitheesuk, B. Chetsawang, and P. Govitrapong, “Effects of melatonin on nervous system aging: neurogenesis and neurodegeneration,” Journal of Pharmacological Sciences, vol. 123, no. 1, pp. 9–24, 2013. View at Publisher · View at Google Scholar · View at Scopus
  103. Y. Yang, S. Jiang, Y. Dong et al., “Melatonin prevents cell death and mitochondrial dysfunction via a SIRT1-dependent mechanism during ischemic-stroke in mice,” Journal of Pineal Research, vol. 58, no. 1, pp. 61–70, 2015. View at Publisher · View at Google Scholar · View at Scopus
  104. A. Corrales, R. Vidal, S. García et al., “Chronic melatonin treatment rescues electrophysiological and neuromorphological deficits in a mouse model of Down syndrome,” Journal of Pineal Research, vol. 56, no. 1, pp. 51–61, 2014. View at Publisher · View at Google Scholar · View at Scopus
  105. V. H. Ozacmak, F. Barut, and H. S. Ozacmak, “Melatonin provides neuroprotection by reducing oxidative stress and HSP70 expression during chronic cerebral hypoperfusion in ovariectomized rats,” Journal of Pineal Research, vol. 47, no. 2, pp. 156–163, 2009. View at Publisher · View at Google Scholar · View at Scopus
  106. S. R. Pandi-Perumal, A. S. Bahammam, G. M. Brown et al., “Melatonin antioxidative defense: therapeutical implications for aging and neurodegenerative processes,” Neurotoxicity Research, vol. 23, no. 3, pp. 267–300, 2013. View at Publisher · View at Google Scholar · View at Scopus
  107. X. Wang, “The antiapoptotic activity of melatonin in neurodegenerative diseases,” CNS Neuroscience and Therapeutics, vol. 15, no. 4, pp. 345–357, 2009. View at Publisher · View at Google Scholar · View at Scopus
  108. C.-M. Chern, J.-F. Liao, Y.-H. Wang, and Y.-C. Shen, “Melatonin ameliorates neural function by promoting endogenous neurogenesis through the MT2 melatonin receptor in ischemic-stroke mice,” Free Radical Biology and Medicine, vol. 52, no. 9, pp. 1634–1647, 2012. View at Publisher · View at Google Scholar · View at Scopus
  109. V. K. Rao, E. A. Carlson, and S. S. Yan, “Mitochondrial permeability transition pore is a potential drug target for neurodegeneration,” Biochimica et Biophysica Acta—Molecular Basis of Disease, vol. 1842, no. 8, pp. 1267–1272, 2014. View at Publisher · View at Google Scholar · View at Scopus
  110. N. R. Sims and H. Muyderman, “Mitochondria, oxidative metabolism and cell death in stroke,” Biochimica et Biophysica Acta—Molecular Basis of Disease, vol. 1802, no. 1, pp. 80–91, 2010. View at Publisher · View at Google Scholar · View at Scopus
  111. M. K. E. Schäfer, A. Pfeiffer, M. Jaeckel, A. Pouya, A. M. Dolga, and A. Methner, “Regulators of mitochondrial Ca2+ homeostasis in cerebral ischemia,” Cell and Tissue Research, vol. 357, no. 2, pp. 395–405, 2014. View at Publisher · View at Google Scholar · View at Scopus
  112. G. Yu, F. Wu, and E.-S. Wang, “BQ-869, a novel NMDA receptor antagonist, protects against excitotoxicity and attenuates cerebral ischemic injury in stroke,” International Journal of Clinical and Experimental Pathology, vol. 8, no. 2, pp. 1213–1225, 2015. View at Google Scholar
  113. X. Wang, “The antiapoptotic activity of melatonin in neurodegenerative diseases,” CNS Neuroscience & Therapeutics, vol. 15, no. 4, pp. 345–357, 2009. View at Publisher · View at Google Scholar
  114. Y. Gouriou, P. Bijlenga, and N. Demaurex, “Mitochondrial Ca2+ uptake from plasma membrane Cav3.2 protein channels contributes to ischemic toxicity in PC12 cells,” The Journal of Biological Chemistry, vol. 288, no. 18, pp. 12459–12468, 2013. View at Publisher · View at Google Scholar · View at Scopus
  115. P.-O. Koh, “Melatonin regulates the calcium-buffering proteins, parvalbumin and hippocalcin, in ischemic brain injury,” Journal of Pineal Research, vol. 53, no. 4, pp. 358–365, 2012. View at Publisher · View at Google Scholar · View at Scopus
  116. P. Bhattacharya, A. K. Pandey, S. Paul, and R. Patnaik, “Melatonin renders neuroprotection by protein kinase C mediated aquaporin-4 inhibition in animal model of focal cerebral ischemia,” Life Sciences, vol. 100, no. 2, pp. 97–109, 2014. View at Publisher · View at Google Scholar · View at Scopus
  117. H. Alluri, C. A. Shaji, M. L. Davis, and B. Tharakan, “Oxygen-glucose deprivation and reoxygenation as an in vitro ischemia-reperfusion injury model for studying blood-brain barrier dysfunction,” Journal of Visualized Experiments, no. 99, Article ID e52699, 2015. View at Publisher · View at Google Scholar
  118. E. Esposito and S. Cuzzocrea, “Antiinflammatory activity of melatonin in central nervous system,” Current Neuropharmacology, vol. 8, no. 3, pp. 228–242, 2010. View at Publisher · View at Google Scholar · View at Scopus
  119. W. Balduini, S. Carloni, S. Perrone et al., “The use of melatonin in hypoxic-ischemic brain damage: an experimental study,” Journal of Maternal-Fetal and Neonatal Medicine, vol. 25, no. 1, pp. 119–124, 2012. View at Publisher · View at Google Scholar · View at Scopus
  120. K. Liang, Y. Ye, Y. Wang, J. Zhang, and C. Li, “Formononetin mediates neuroprotection against cerebral ischemia/reperfusion in rats via downregulation of the Bax/Bcl-2 ratio and upregulation PI3K/Akt signaling pathway,” Journal of the Neurological Sciences, vol. 344, no. 1-2, pp. 100–104, 2014. View at Publisher · View at Google Scholar · View at Scopus
  121. Z. Pei and R. T. Cheung, “Pretreatment with melatonin exerts anti-inflammatory effects against ischemia/reperfusion injury in a rat middle cerebral artery occlusion stroke model,” Journal of Pineal Research, vol. 37, no. 2, pp. 85–91, 2004. View at Google Scholar
  122. Y. Feng, S. Lu, J. Wang, P. Kumar, L. Zhang, and A. J. Bhatt, “Dexamethasone-induced neuroprotection in hypoxic-ischemic brain injury in newborn rats is partly mediated via Akt activation,” Brain Research, vol. 1589, pp. 68–77, 2014. View at Publisher · View at Google Scholar · View at Scopus
  123. A. Hafeez, O. Elmadhoun, C. Peng et al., “Reduced apoptosis by ethanol and its association with PKC-δ and Akt signaling in ischemic stroke,” Aging and Disease, vol. 5, no. 6, pp. 366–372, 2014. View at Google Scholar
  124. Y. Zheng, J. Hou, J. Liu et al., “Inhibition of autophagy contributes to melatonin-mediated neuroprotection against transient focal cerebral ischemia in rats,” Journal of Pharmacological Sciences, vol. 124, no. 3, pp. 354–364, 2014. View at Publisher · View at Google Scholar · View at Scopus
  125. L. Zhao, X. Liu, J. Liang et al., “Phosphorylation of p38 MAPK mediates hypoxic preconditioning-induced neuroprotection against cerebral ischemic injury via mitochondria translocation of Bcl-xL in mice,” Brain Research, vol. 1503, pp. 78–88, 2013. View at Publisher · View at Google Scholar · View at Scopus
  126. P.-O. Koh, “Melatonin attenuates the cerebral ischemic injury via the MEK/ERK/p90RSK/Bad signaling cascade,” Journal of Veterinary Medical Science, vol. 70, no. 11, pp. 1219–1223, 2008. View at Publisher · View at Google Scholar · View at Scopus
  127. F. Luchetti, B. Canonico, M. Betti et al., “Melatonin signaling and cell protection function,” The FASEB Journal, vol. 24, no. 10, pp. 3603–3624, 2010. View at Publisher · View at Google Scholar · View at Scopus
  128. Ü. Kilic, E. Kilic, R. J. Reiter, C. L. Bassetti, and D. M. Hermann, “Signal transduction pathways involved in melatonin-induced neuroprotection after focal cerebral ischemia in mice,” Journal of Pineal Research, vol. 38, no. 1, pp. 67–71, 2005. View at Publisher · View at Google Scholar · View at Scopus
  129. P.-O. Koh, “Melatonin prevents ischemic brain injury through activation of the mTOR/p70S6 kinase signaling pathway,” Neuroscience Letters, vol. 444, no. 1, pp. 74–78, 2008. View at Publisher · View at Google Scholar · View at Scopus
  130. E. Kilic, Ü. Kilic, R. J. Reiter, C. L. Bassetti, and D. M. Hermann, “Prophylactic use of melatonin protects against focal cerebral ischemia in mice: role of endothelin converting enzyme-1,” Journal of Pineal Research, vol. 37, no. 4, pp. 247–251, 2004. View at Publisher · View at Google Scholar · View at Scopus
  131. E. Parada, I. Buendia, R. León et al., “Neuroprotective effect of melatonin against ischemia is partially mediated by alpha-7 nicotinic receptor modulation and HO-1 overexpression,” Journal of Pineal Research, vol. 56, no. 2, pp. 204–212, 2014. View at Publisher · View at Google Scholar · View at Scopus
  132. J. Vanecek, “Cellular mechanisms of melatonin action,” Physiological Reviews, vol. 78, no. 3, pp. 687–721, 1998. View at Google Scholar · View at Scopus
  133. C. H. Lee, K.-Y. Yoo, J. H. Choi et al., “Melatonin's protective action against ischemic neuronal damage is associated with up-regulation of the MT2 melatonin receptor,” Journal of Neuroscience Research, vol. 88, no. 12, pp. 2630–2640, 2010. View at Publisher · View at Google Scholar · View at Scopus
  134. U. Kilic, B. Yilmaz, M. Ugur et al., “Evidence that membrane-bound G protein-coupled melatonin receptors MT1 and MT2 are not involved in the neuroprotective effects of melatonin in focal cerebral ischemia,” Journal of Pineal Research, vol. 52, no. 2, pp. 228–235, 2012. View at Publisher · View at Google Scholar · View at Scopus